Personen

Prof. Dr. F. Markus Leweke

Tel.: 0621 1703-2321

Fax: 0621 1703-2305

E-Mail

Sekretariat: Silvia Adum-Batista E-Mail
Tel.: 0621 1703-2322, Fax: -2305

Therapiegebäude, 1. OG, Raum 112 

Publikationen

Publikationen in peer-reviewed Zeitschriften seit 2006

TOP 5 Publikationen:

  1. Grass G, Hellmich M, Leweke FM. Clozapine alone versus clozapine and risperidone for refractory schizophrenia. N Engl J Med. 2006 354(17):1846-8; author reply 1846-8.
  2. Guest PC, Wang L, Harris LW, Burling K, Levin Y, Ernst A, Wayland MT, Umrania Y, Herberth M, Koethe D, van Beveren JM, Rothermundt M, McAllister G, Leweke FM, Steiner J, Bahn S. Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients. Mol Psychiatry. 2010 15(2):118-9.
  3. Levin Y, Wang L, Schwarz E, Koethe D, Leweke FM, Bahn S. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol Psychiatry. 2010 15(11):1088-100. Epub 2009 Jun 23.
  4. Herberth M, Krzyszton DN, Koethe D, Craddock MR, Bulger E, Schwarz E, Guest P, Leweke FM, Bahn S. Differential effects on T-cell function following exposure to serum from schizophrenia smokers. Mol Psychiatry. 2010 15(4):364-71. Epub 2008 Nov 11.
  5. Coughlin JM, Ishizuka K, Kano SI, Edwards JA, Seifuddin FT, Shimano MA, Daley EL, Zandi PP, Leweke FM, Cascella NG, Pomper MG, Yolken RH, Sawa A. Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia. Mol Psychiatry. 2013 18(1):10-1.